CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $755,976 | -37.5% | 328,685 | -0.8% | 0.00% | – |
Q2 2023 | $1,209,738 | +332.8% | 331,435 | +323.3% | 0.00% | – |
Q1 2023 | $279,531 | +56.7% | 78,300 | +25.1% | 0.00% | – |
Q4 2022 | $178,379 | +28.3% | 62,589 | 0.0% | 0.00% | – |
Q3 2022 | $139,000 | -7.3% | 62,589 | +3.5% | 0.00% | – |
Q2 2022 | $150,000 | -89.9% | 60,474 | -80.1% | 0.00% | – |
Q1 2022 | $1,486,000 | -58.5% | 304,346 | -3.8% | 0.00% | -100.0% |
Q4 2021 | $3,579,000 | -20.7% | 316,467 | +2.2% | 0.00% | 0.0% |
Q3 2021 | $4,513,000 | +21.3% | 309,770 | -3.0% | 0.00% | 0.0% |
Q2 2021 | $3,721,000 | -7.8% | 319,315 | -3.4% | 0.00% | 0.0% |
Q1 2021 | $4,035,000 | -6.2% | 330,694 | -3.8% | 0.00% | 0.0% |
Q4 2020 | $4,300,000 | -17.8% | 343,745 | -1.1% | 0.00% | 0.0% |
Q3 2020 | $5,230,000 | -39.2% | 347,532 | -1.0% | 0.00% | -50.0% |
Q2 2020 | $8,608,000 | +156.6% | 351,218 | +48.5% | 0.00% | +100.0% |
Q1 2020 | $3,355,000 | -4.0% | 236,474 | +7.5% | 0.00% | 0.0% |
Q4 2019 | $3,493,000 | +85.2% | 220,073 | -1.6% | 0.00% | – |
Q3 2019 | $1,886,000 | +2.6% | 223,652 | +9.3% | 0.00% | – |
Q2 2019 | $1,839,000 | +18.6% | 204,555 | +2.0% | 0.00% | – |
Q1 2019 | $1,551,000 | +74.1% | 200,585 | +5.8% | 0.00% | – |
Q4 2018 | $891,000 | -48.4% | 189,572 | -0.7% | 0.00% | – |
Q3 2018 | $1,728,000 | -19.3% | 190,973 | +5.8% | 0.00% | -100.0% |
Q2 2018 | $2,141,000 | +102.7% | 180,486 | +140.2% | 0.00% | – |
Q1 2018 | $1,056,000 | – | 75,153 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |